{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:50:11Z","timestamp":1784609411980,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:00Z","timestamp":1494979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00108-017-0234-z","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T13:41:20Z","timestamp":1495028480000},"page":"866-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Schwere Hypertriglyzerid\u00e4mie","Severe hypertriglyceridemia"],"prefix":"10.1007","volume":"58","author":[{"given":"U.","family":"Kassner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dippel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Steinhagen-Thiessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"issue":"8","key":"234_CR1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","volume":"2","author":"RA Hegele","year":"2014","unstructured":"European Atherosclerosis Society Consensus Panel, Hegele RA et\u00a0al (2014) The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol 2(8):655\u2013666","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"234_CR2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.15.4.534","volume":"15","author":"BG Nordestgaard","year":"1995","unstructured":"Nordestgaard BG, Wootton R, Lewis B (1995) Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a\u00a0determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol 15(4):534\u2013542","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"234_CR3","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1161\/01.RES.0000265132.99997.d3","volume":"100","author":"GD Norata","year":"2007","unstructured":"Norata GD, Catapano AL (2007) Triglyceride-rich lipoproteins from normotrygliceridemic subjects and hyperlipidemic patients differently affect endothelial cell activation and gene expression patterns. Circ Res 100(7):e81\u201317431191","journal-title":"Circ Res"},{"issue":"10","key":"234_CR4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1194\/jlr.M200135-JLR200","volume":"43","author":"M Guerin","year":"2002","unstructured":"Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ (2002) Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state. J\u00a0Lipid Res 43(10):1652\u20131660","journal-title":"J Lipid Res"},{"issue":"11","key":"234_CR5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"MJ Chapman","year":"2011","unstructured":"Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Bor\u00e9n J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokg\u00f6zoglu L, Tybj\u00e6rg-Hansen A, Watts GF, European Atherosclerosis Society Consensus Panel (2011) Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart\u00a0J 32(11):1345\u20131361","journal-title":"Eur Heart J"},{"issue":"3","key":"234_CR6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298(3):299\u2013308","journal-title":"JAMA"},{"issue":"18","key":"234_CR7","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2008.621","volume":"300","author":"JJ Freiberg","year":"2008","unstructured":"Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG (2008) Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 300(18):2142\u20132152","journal-title":"JAMA"},{"issue":"4","key":"234_CR8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","volume":"61","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybj\u00e6rg-Hansen A, J\u00f8rgensen AB, Frikke-Schmidt R, Nordestgaard BG (2013) Remnant cholesterol as a\u00a0causal risk factor for ischemic heart disease. J\u00a0Am Coll Cardiol 61(4):427\u2013436","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"234_CR9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","volume":"298","author":"S Bansal","year":"2007","unstructured":"Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298(3):309\u2013316","journal-title":"JAMA"},{"issue":"24","key":"234_CR10","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","volume":"34","author":"AB J\u00f8rgensen","year":"2013","unstructured":"J\u00f8rgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybj\u00e6rg-Hansen A (2013) Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart\u00a0J 34(24):1826\u20131833","journal-title":"Eur Heart J"},{"issue":"23","key":"234_CR11","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2014.09.042","volume":"64","author":"RS Rosenson","year":"2014","unstructured":"Rosenson RS, Davidson MH, Hirsh BJ, Kathiresan S, Gaudet D (2014) Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. J\u00a0Am Coll Cardiol 64(23):2525\u20132540","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"234_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2011.08.012","volume":"220","author":"KG Jackson","year":"2012","unstructured":"Jackson KG, Poppitt SD, Minihane AM (2012) Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants. Atherosclerosis 220(1):22\u201333","journal-title":"Atherosclerosis"},{"issue":"9729","key":"234_CR13","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(10)60656-3","volume":"375","author":"M Jun","year":"2010","unstructured":"Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls SJ, Grobbee DE, Cass A, Chalmers J, Perkovic V (2010) Effects of fibrates on cardiovascular outcomes: a\u00a0systematic review and meta-analysis. Lancet 375(9729):1875\u20131884","journal-title":"Lancet"},{"issue":"7","key":"234_CR14","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMc1006407","volume":"363","author":"FM Sacks","year":"2010","unstructured":"Sacks FM, Carey VJ, Fruchart JC (2010) Combination lipid therapy in type 2 diabetes. N\u00a0Engl J Med 363(7):692\u2013694","journal-title":"N Engl J Med"},{"issue":"24","key":"234_CR15","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","volume":"365","author":"WE Boden","year":"2011","unstructured":"AIM-HIGH Investigators, Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W (2011) Niacin inpatients with low HDL cholesterol levels receiving intensive statin therapy. N\u00a0Engl J Med 365(24):2255\u20132267","journal-title":"N Engl J Med"},{"issue":"10","key":"234_CR16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/2012.jama.11374","volume":"308","author":"EC Rizos","year":"2012","unstructured":"Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a\u00a0systematic review and meta-analysis. JAMA 308(10):1024\u20131033","journal-title":"JAMA"},{"key":"234_CR17","volume-title":"\u201cFamilial lipoprotein lipase deficiency\u201d in genereviews\u00ae","author":"JD Brunzell","year":"1999","unstructured":"Brunzell JD (1999) \u201cFamilial lipoprotein lipase deficiency\u201d in genereviews\u00ae. \n                        http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1308\/\n                        \n                    . Zugegriffen: 24. Apr 2014"},{"issue":"8","key":"234_CR18","first-page":"689","volume":"25","author":"P Valdivielso","year":"2014","unstructured":"Valdivielso P, Ram\u00edrez-Bueno A, Ewald N (2014) Current knowledge of hypertriglyceridemic pancreatitis. J\u00a0Intern Med 25(8):689\u2013694","journal-title":"J Intern Med"},{"key":"234_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijsu.2015.08.080","volume":"23","author":"A Charlesworth","year":"2015","unstructured":"Charlesworth A, Steger A, Crook MA (2015) Acute pancreatitis associated with severe hypertriglyceridaemia; a retrospective cohort study. Int J Surg 23:23\u201327","journal-title":"Int J Surg"},{"key":"234_CR20","first-page":"17","volume":"2","author":"WF Riesen","year":"2012","unstructured":"Riesen WF (2012) Das Blutzuckerged\u00e4chtnis HbA1c \u2013 Langzeiterfassung der Blutzuckerkonzentration. Inf Arzt 2:17\u201318","journal-title":"Inf Arzt"},{"key":"234_CR21","unstructured":"Genetic Home Reference \u2013 a\u00a0service of the US Library of Medicine accessible via \n                        http:\/\/ghr.nlm.nih.gov\/gene\/LPL\n                        \n                    . Zugegriffen: 1.\u00a0April 2015"},{"key":"234_CR22","unstructured":"Gendiagnostikgesetz (GenDG) vom 31. Juli 2009 (BGBI.I S.\u00a02529, 3672) das durch Art.\u00a02 Abs 31 und Art 4 Abs 18 des Gesetzes vom 7. August 2013 (BGBI.I S.\u00a03154) ge\u00e4ndert worden ist. Einsehbar unter \n                        http:\/\/www.gesetze-im-internet.de\/bundesrecht\/gendg\/gesamt.pdf"},{"issue":"4","key":"234_CR23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacl.2015.03.012","volume":"9","author":"KS Rhodes","year":"2015","unstructured":"Rhodes KS, Weintraub M, Marchlewicz EH, Rubenfire M, Brook RD et\u00a0al (2015) Medical nutrition therapy is the essential cornerstone for effective treatment of \u201crefractory\u201d severe hypertriglyceridemia regardless of pharmaceutical treatment: evidence from a\u00a0Lipid Management Program. J\u00a0Clin Lipidol 9(4):559\u2013567","journal-title":"J Clin Lipidol"},{"issue":"8","key":"234_CR24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","volume":"176","author":"G Yuan","year":"2007","unstructured":"Yuan G, Al-Shali KZ, Hegele RA (2007) Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 176(8):1113\u20131120","journal-title":"CMAJ"},{"issue":"19","key":"234_CR25","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","volume":"98","author":"B Staels","year":"1998","unstructured":"Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98(19):2088\u20132093","journal-title":"Circulation"},{"issue":"9493","key":"234_CR26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists\u2019 (CTT) Collaborators (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493):1267\u20131278","journal-title":"Lancet"},{"issue":"2","key":"234_CR27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2012.02.016","volume":"223","author":"D Morrone","year":"2012","unstructured":"Morrone D, Weintraub WS, Toth PP, Hanson ME, Lowe RS, Lin J, Shah AK, Tershakovec AM (2012) Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a\u00a0pooled analysis of over 21,000 subjects from 27 clinical trials. Atherosclerosis 223(2):251\u2013261","journal-title":"Atherosclerosis"},{"issue":"8","key":"234_CR28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4103\/0972-5229.162472","volume":"19","author":"P Nasa","year":"2015","unstructured":"Nasa P, Alexander G, Kulkarni A, Juneja D, Sehra S, Agarwal R, Koul K (2015) Early plasmapheresis in patients with severe hypertriglyceridemia induced acute pancreatitis. Indian J Crit Care Med 19(8):487\u2013489","journal-title":"Indian J Crit Care Med"},{"key":"234_CR29","unstructured":"Glybera (alipogene tiparvovec). Summary of Product Characteristics. uniQure biopharma B.V. Amsterdam, The Netherlands. Accessed at: \n                        http:\/\/www.ema.europa.eu\/\n                        \n                    . Zugegriffen: 1. April 2015."},{"issue":"4","key":"234_CR30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOL.0b013e3283555a7e","volume":"23","author":"D Gaudet","year":"2012","unstructured":"Gaudet D, M\u00e9thot J, Kastelein J (2012) Gene therapy for lipoprotein lipase deficiency. Curr Opin Lipidol 23(4):310\u2013320","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"234_CR31","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1210\/jc.2011-3002","volume":"97","author":"AC Carpentier","year":"2012","unstructured":"Carpentier AC, Frisch F, Labb\u00e9 SM, Gagnon R, de Wal J, Greentree S, Petry H, Twisk J, Brisson D, Gaudet D (2012) Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients. J\u00a0Clin Endocrinol Metab 97(5):1635\u20131644","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"234_CR32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","volume":"20","author":"D Gaudet","year":"2013","unstructured":"Gaudet D, M\u00e9thot J, D\u00e9ry S, Brisson D, Essiembre C, Tremblay G, Tremblay K, de Wal J, Twisk J, van den Bulk N, Sier-Ferreira V, van Deventer S (2013) Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Ther 20(4):361\u2013369","journal-title":"Gene Ther"},{"issue":"2","key":"234_CR33","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.atherosclerosis.2014.05.007","volume":"235","author":"D Gaudet","year":"2014","unstructured":"Gaudet D, Stroes E, Bruno M, Andersen M, Petry H, Meyer C (2014) Gene therapy with alipogene tiparvovec (Glybera\u00ae) for the prevention of LPLD induced pancreatitis: Follow-up data suggests long-term clinical benefit. Atherosclerosis 235(2):e13","journal-title":"Atherosclerosis"},{"issue":"23","key":"234_CR34","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","volume":"371","author":"D Gaudet","year":"2014","unstructured":"Gaudet D, Brisson D, Tremblay K, Alexander VJ, Singleton W, Hughes SG, Geary RS, Baker BF, Graham MJ, Crooke RM, Witztum JL (2014) Targeting APOC3 in the familial chylomicronemia syndrome. N\u00a0Engl J Med 371(23):2200\u20132206","journal-title":"N Engl J Med"},{"issue":"1","key":"234_CR35","doi-asserted-by":"crossref","first-page":"Abstract # 0854","DOI":"10.1016\/j.atherosclerosis.2015.04.482","volume":"241","author":"E Steinhagen-Thiessen","year":"2015","unstructured":"Steinhagen-Thiessen E, Stroes E, Soran H, Johnson C, Moulin P, Iotti G, Zibellini M, Ossenkoppele B, Dippel M, Averna M, GENIALL Investigators (2015) First global, longitudinal, pharmaco-epidemiologic, observational registry on GENe therapy In the ManAgement of Lipoprotein Lipase Deficiency (GENIALL). Atherosclerosis 241(1):Abstract # 0854 (presented as Poster at EAS Congress 2015 in Glasgow)","journal-title":"Atherosclerosis"},{"issue":"3","key":"234_CR36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/157016111795495585","volume":"9","author":"BG Nordestgaard","year":"2011","unstructured":"Nordestgaard BG, Freiberg JJ (2011) Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol. Curr Vasc Pharmacol 9(3):281\u2013286","journal-title":"Curr Vasc Pharmacol"},{"issue":"8","key":"234_CR37","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1194\/jlr.P800011-JLR200","volume":"49","author":"CR Pullinger","year":"2008","unstructured":"Pullinger CR, Aouizerat BE, Movsesyan I, Durlach V, Sijbrands EJ, Nakajima K, Poon A, Dallinga-Thie GM, Hattori H, Green LL, Kwok PY, Havel RJ, Frost PH, Malloy MJ, Kane JP (2008) An apolipoprotein A\u2011V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients. J\u00a0Lipid Res 49(8):1846\u20131854","journal-title":"J Lipid Res"},{"issue":"4","key":"234_CR38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","volume":"5","author":"AP Beigneux","year":"2007","unstructured":"Beigneux AP, Davies BS, Gin P, Weinstein MM, Farber E, Qiao X, Peale F, Bunting S, Walzem RL, Wong JS, Blaner WS, Ding ZM, Melford K, Wongsiriroj N, Shu X, de Sauvage F, Ryan RO, Fong LG, Bensadoun A, Young SG (2007) Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a\u00a0critical role in the lipolytic processing of chylomicrons. Cell Metab 5(4):279\u2013291","journal-title":"Cell Metab"},{"issue":"12","key":"234_CR39","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2007.24","volume":"39","author":"M P\u00e9terfy","year":"2007","unstructured":"P\u00e9terfy M, Ben-Zeev O, Mao HZ, Weissglas-Volkov D, Aouizerat BE, Pullinger CR, Frost PH, Kane JP, Malloy MJ, Reue K, Pajukanta P, Doolittle MH (2007) Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat Genet 39(12):1483\u20131487","journal-title":"Nat Genet"},{"key":"234_CR40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1101\/gad.209296.112","volume":"27","author":"SG Young","year":"2013","unstructured":"Young SG, Zechner R (2013) Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev 27:459\u2013484","journal-title":"Genes Dev"},{"issue":"27998715","key":"234_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.002","volume":"23","author":"E Stroes","year":"2017","unstructured":"Stroes E, Moulin P, Parhofer KG, Rebours V, L\u00f6hr JM, Averna M (2017) Diagnostic algorithm for familial chylomicronemia syndrome. Atheroscler Suppl 23:1\u20137","journal-title":"Atheroscler Suppl"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-017-0234-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0234-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0234-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T10:35:29Z","timestamp":1501151729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-017-0234-z"}},"subtitle":["Diagnostik und neue Therapieprinzipien","Diagnostics and new treatment principles"],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1007\/s00108-017-0234-z","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,17]]}}}